Published online before print April 4, 2002, doi: 10.1161/01.RES.0000017629.70769.CC
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2002 American Heart Association, Inc.
Molecular Medicine |
Angiotensin II Induces Myocyte Enhancer Factor 2- and Calcineurin/Nuclear Factor of Activated T Cell-Dependent Transcriptional Activation in Vascular Myocytes
From the Department of Internal Medicine (E.S., H.S., A.G., M.O., T.F., R.N., Y.H.) and the Department of Urology (H.N.), Faculty of Medicine, University of Tokyo, Tokyo, Japan, and the Cardiovascular Research Institute (K.W.), Boston University School of Medicine, Boston, Mass.
Correspondence to Etsu Suzuki, MD, PhD, Division of Nephrology and Endocrinology No. 202, Department of Internal Medicine, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail suzuki-2im{at}h.u-tokyo.ac.jp
It is well known that angiotensin II (Ang II) is implicated in the phenotypic modulation and hypertrophy of vascular smooth muscle cells (VSMCs). To study the mechanisms by which Ang II contributes to the pathological changes of VSMCs, we examined whether Ang II stimulated myocyte enhancer factor 2 (MEF2)- and calcineurin/nuclear factor of activated T cell (NFAT)-dependent transcriptional activation of genes in VSMCs. Ang II increased the DNA binding activity of MEF2A and its expression at the protein level. Ang II induced c-jun promoter activity, and this increase was inhibited by dominant-negative mutants of MEF2A and mitogen-activated protein kinase kinase 6 but not by calcineurin inhibitors. Ang II stimulated NFAT DNA binding activity and NFAT-dependent gene transcription, and these effects of Ang II were inhibited by calcineurin inhibitors. Furthermore, Ang II induced the promoter activity of the nonmuscle-type myosin heavy chain B gene, which we used as a marker of the dedifferentiated state of VSMCs, and this increase was inhibited by calcineurin inhibitors but not by the dominant-negative mutants of MEF2A or mitogen-activated protein kinase kinase 6. Finally, Ang II increased protein synthesis, and this increase was inhibited by infection with an adenovirus construct that expresses the dominant-negative mutant of MEF2A but not by calcineurin inhibitors. These results suggest that Ang II stimulates the MEF2- and calcineurin/NFAT-dependent pathways and that these pathways have distinct roles in VSMCs.
Key Words: angiotensin II • myocyte enhancer factor 2 • calcineurin/nuclear factor of activated T cells • vascular smooth muscle cells • atherosclerosis
This article has been cited by other articles:
 |
|
 |
|
  M. Takahashi, E. Suzuki, R. Takeda, S. Oba, H. Nishimatsu, K. Kimura, T. Nagano, R. Nagai, and Y. Hirata Angiotensin II and tumor necrosis factor-{alpha} synergistically promote monocyte chemoattractant protein-1 expression: roles of NF-{kappa}B, p38, and reactive oxygen species Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2879 - H2888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Takeda, E. Suzuki, M. Takahashi, S. Oba, H. Nishimatsu, K. Kimura, T. Nagano, R. Nagai, and Y. Hirata Calcineurin is critical for sodium-induced neointimal formation in normotensive and hypertensive rats Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2871 - H2878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lipskaia, C. Pinet, Y. Fromes, S. Hatem, I. Cantaloube, A. Coulombe, and A.-M. Lompre Mutation of {delta}-Sarcoglycan Is Associated with Ca2+-Dependent Vascular Remodeling in the Syrian Hamster Am. J. Pathol., July 1, 2007; 171(1): 162 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Nilsson, Z.-W. Sun, J. Nilsson, I. Nordstrom, Y.-W. Chen, J. D. Molkentin, D. Wide-Swensson, P. Hellstrand, M.-L. Lydrup, and M. F. Gomez Novel blocker of NFAT activation inhibits IL-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferation Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1167 - C1178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Gooch An emerging role for calcineurin A{alpha} in the development and function of the kidney Am J Physiol Renal Physiol, April 1, 2006; 290(4): F769 - F776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang, P. Paradis, A. Aries, H. Komati, C. Lefebvre, H. Wang, and M. Nemer Convergence of Protein Kinase C and JAK-STAT Signaling on Transcription Factor GATA-4 Mol. Cell. Biol., November 15, 2005; 25(22): 9829 - 9844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lipskaia, F. del Monte, T. Capiod, S. Yacoubi, L. Hadri, M. Hours, R. J. Hajjar, and A.-M. Lompre Sarco/Endoplasmic Reticulum Ca2+-ATPase Gene Transfer Reduces Vascular Smooth Muscle Cell Proliferation and Neointima Formation in the Rat Circ. Res., September 2, 2005; 97(5): 488 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Mitchell, A. L. DeStefano, M. G. Larson, E. J. Benjamin, M.-H. Chen, R. S. Vasan, J. A. Vita, and D. Levy Heritability and a Genome-Wide Linkage Scan for Arterial Stiffness, Wave Reflection, and Mean Arterial Pressure: The Framingham Heart Study Circulation, July 12, 2005; 112(2): 194 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Guo, M. Lopez-Ilasaca, and V. J. Dzau Identification of Calcium-modulating Cyclophilin Ligand (CAML) as Transducer of Angiotensin II-mediated Nuclear Factor of Activated T Cells (NFAT) Activation J. Biol. Chem., April 1, 2005; 280(13): 12536 - 12541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Inokuchi, T Morohashi, I Kawana, Y Nagashima, M Kihara, and S Umemura Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice Gut, March 1, 2005; 54(3): 349 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Amberg, C. F. Rossow, M. F. Navedo, and L. F. Santana NFATc3 Regulates Kv2.1 Expression in Arterial Smooth Muscle J. Biol. Chem., November 5, 2004; 279(45): 47326 - 47334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Gooch, J. J. Toro, R. L. Guler, and J. L. Barnes Calcineurin A-{alpha} But Not A-{beta} Is Required for Normal Kidney Development and Function Am. J. Pathol., November 1, 2004; 165(5): 1755 - 1765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mathew, E. Mascareno, and M. A. Q. Siddiqui A Ternary Complex of Transcription Factors, Nished and NFATc4, and Co-activator p300 Bound to an Intronic Sequence, Intronic Regulatory Element, Is Pivotal for the Up-regulation of Myosin Light Chain-2v Gene in Cardiac Hypertrophy J. Biol. Chem., September 24, 2004; 279(39): 41018 - 41027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. DeStefano, M. G. Larson, G. F. Mitchell, E. J. Benjamin, R. S. Vasan, J. Li, D. Corey, and D. Levy Genome-Wide Scan for Pulse Pressure in the National Heart, Lung and Blood Institute's Framingham Heart Study Hypertension, August 1, 2004; 44(2): 152 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Suzuki, H. Satonaka, H. Nishimatsu, S. Oba, R. Takeda, M. Omata, T. Fujita, R. Nagai, and Y. Hirata Myocyte Enhancer Factor 2 Mediates Vascular Inflammation via the p38-Dependent Pathway Circ. Res., July 9, 2004; 95(1): 42 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Satonaka, E. Suzuki, H. Nishimatsu, S. Oba, R. Takeda, A. Goto, M. Omata, T. Fujita, R. Nagai, and Y. Hirata Calcineurin Promotes the Expression of Monocyte Chemoattractant Protein-1 in Vascular Myocytes and Mediates Vascular Inflammation Circ. Res., March 19, 2004; 94(5): 693 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Suzuki, M. Ruiz-Ortega, C. Gomez-Guerrero, Y. Tomino, and J. Egido Angiotensin II, the immune system and renal diseases: another road for RAS? Nephrol. Dial. Transplant., August 1, 2003; 18(8): 1423 - 1426. [Full Text] [PDF]
|
|
|
|
|
|
Y. Suzuki, M. Ruiz-Ortega, C. Gomez-Guerrero, Y. Tomino, and J. Egido Angiotensin II, the immune system and renal diseases: another road for RAS? Nephrol. Dial. Transplant., August 1, 2003; 18(88): 1423 - 1426. [Full Text]
|
|
|
|
|
|
W. Nadruz Jr, C. B. Kobarg, S. S. Constancio, P. D.C. Corat, and K. G. Franchini Load-Induced Transcriptional Activation of c-jun in Rat Myocardium: Regulation by Myocyte Enhancer Factor 2 Circ. Res., February 7, 2003; 92(2): 243 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. van Rooij, P. A. Doevendans, C. C. de Theije, F. A. Babiker, J. D. Molkentin, and L. J. De Windt Requirement of Nuclear Factor of Activated T-cells in Calcineurin-mediated Cardiomyocyte Hypertrophy J. Biol. Chem., December 6, 2002; 277(50): 48617 - 48626. [Abstract] [Full Text] [PDF]
|
|